A detailed history of Stanley Laman Group, Ltd. transactions in Novartis Ag stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 2,225 shares of NVS stock, worth $216,003. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,225
Previous 2,225 -0.0%
Holding current value
$216,003
Previous $236,000 8.05%
% of portfolio
0.04%
Previous 0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$92.57 - $107.37 $205,968 - $238,898
2,225 New
2,225 $236,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Stanley Laman Group, Ltd. Portfolio

Follow Stanley Laman Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.